USP8 and ovarian endometrioid carcinoma: When we examined USP8 expression levels and activity in different ovarian carcinoma cell lines including pairs of cisplatin sensitive and resistant cells, we found increased levels in the latter and enhanced activity in cells representative of the endometrioid ovarian carcinoma subtype.